IL10 and glioblastoma: They also found that ICOSLG expression in GBM is inversely correlated with patient survival and induce tumorigenicity in a preclinical model.36 These results indicate that soluble ICOSLG in the TME may suppress antitumor immune responses through regulatory T cells and IL-10.